Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. - Wikidata - awgldk - TriplyDB

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

http://www.wikidata.org/entity/Q37341453

about

SMC complexes link gene expression and genome architecture Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer Cohesin mutations in myeloid malignancies: underlying mechanisms Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis.Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer.Genetic and Epigenetic Alterations in Bladder Cancer Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.Defective sister chromatid cohesion is synthetically lethal with impaired APC/C function.Enhanced copy number variants detection from whole-exome sequencing data using EXCAVATOR2 Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden.Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease.The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.Identification of ALK gene alterations in urothelial carcinoma.Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition Genetic alterations of the cohesin complex genes in myeloid malignancies.Cohesin gene mutations in tumorigenesis: from discovery to clinical significance STAG2 promotes error correction in mitosis by regulating kinetochore-microtubule attachments.Meiotic cohesin STAG3 is required for chromosome axis formation and sister chromatid cohesion Sororin pre-mRNA splicing is required for proper sister chromatid cohesion in human cells.Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene HRAS mutations are frequent in inverted urothelial neoplasms.Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.NOTCH pathway inactivation promotes bladder cancer progression Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.The contribution of cohesin-SA1 to gene expression and chromatin architecture in two murine tissues.Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.Molecular biology of bladder cancer.The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.Intact Cohesion, Anaphase, and Chromosome Segregation in Human Cells Harboring Tumor-Derived Mutations in STAG2.GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation.BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis.De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-Ropers syndrome.BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas.The three-dimensional cancer genome.Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer

P2860

Q26826804-5FF6F764-811D-4A8A-A696-C8AB4971F6E3 Q27008499-9C90010E-FC33-42B2-8F85-8C2BCB40C789 Q27022740-50FB7B36-FD8D-4D3D-B16C-CA534835583C Q27308738-C8E7DAD9-91AE-44B0-974C-FE92C754F7D1 Q27853334-9B94C895-6DF4-426A-BB0E-509567D127DF Q28074732-D1ED626E-E391-4849-9954-361640DD7C48 Q28088334-2D217F8E-A387-448A-82FE-8BA0C7A45C36 Q30279180-008FA2B6-4159-4983-A891-98DC8F48330F Q30667509-1094C7AF-7AF3-46E5-ABFE-F91FDB79F521 Q31120762-945F67C8-2563-4208-BA00-0328C5939EB7 Q33568623-23310924-C788-4223-876B-2B28DD9CCA2D Q33583057-52F55FCB-9C0F-4D2F-96AD-384A70B8B8DA Q33881163-F9D77585-C774-4B0F-A069-3B2358EC4652 Q33989002-FE2B978A-29F3-469A-B848-4DDC528624AE Q34034221-613EF611-39C1-4979-9435-70AF6BE9D86B Q34170374-6CCD97F9-6FDC-4232-9A66-DA2EAF5A9F59 Q34179964-F0D549C2-9793-4F7F-8701-E0A1EFBB8BC9 Q34264526-E0C6526F-77D8-4872-9C50-6F2E2D03525E Q34343224-C2092803-CC3A-4FCA-B49E-30DFA0DDC31A Q34343252-940679BA-BDEA-43DC-A155-C2A8837CE1ED Q34469971-677220CC-EAED-4D16-A333-5BC598FB778A Q34478820-9BE65572-ED7F-4CA7-8DC3-B49ED7E85C2D Q34563001-CB82837D-7746-42FB-ADA5-468A384A3259 Q34691553-97BA5E7B-F739-4246-BEAD-EBCE02DA25A2 Q35034441-485960D9-F9B8-4C83-99D3-625CAEC0CF08 Q35056671-E081D430-99A6-46DE-B0BF-656DDB172B93 Q35215704-E4B5EBED-C8B2-487F-A0CE-6495FF87CAC5 Q35237045-D9802C06-1A3D-4037-A819-E3213F22544C Q35250650-F7E9056D-3412-4193-9510-6C5BA76B9362 Q35266400-E3964408-F725-4E94-B96A-C9B81A424014 Q35638497-705DCAE9-B176-417D-9C63-15A7F257EAC5 Q35922216-AA397889-10BD-4DD3-9CFD-CB29967D4DEF Q36054919-7F1D6D90-61C9-4BA8-9EEB-FA1FA6D65784 Q36180677-B69C9B3D-A930-477C-A254-F579D028F81E Q36352394-D9AB1573-4FC9-4547-9435-6F20B9A0A8F9 Q36506766-24E3EC64-5A83-49C2-A0AF-05187A9E6158 Q36514637-05B1658E-0026-4037-97A8-C2AC24FEEECA Q36545314-AA2A68B7-4048-40D4-9553-B4273F0C83A2 Q36936249-5981E846-5F56-4A82-8CE5-5BC3A3009EE3 Q37053820-A2ECDCF1-F7C9-45F3-BA4D-39BFED2C4957

P2860

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

http://www.wikidata.org/entity/Q37341453

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

@en

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

@nl

type

label

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

@en

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

@nl

prefLabel

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

@en

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

@nl

P1433

Q37341453-76759F61-6F12-47D9-A475-1DB50BC82716

P1476

Q37341453-93CC503A-EB8F-4215-9123-F25ED0C453C0

P2093

Q37341453-06418E5C-7350-40A6-83D3-6435C00CBFA4

Q37341453-0783F095-2E7B-46DA-AEAA-50EA9B25FA66

Q37341453-46A1B444-7112-4AE2-A8EA-7E3BDC983DBC

Q37341453-47F5E7B3-3525-41CC-A929-1679033FCCD3

Q37341453-5DE1E710-6787-4476-8B8D-AE86DAE1528B

Q37341453-76C8F503-2B02-4A45-B9C8-3DC16F8B3D97

Q37341453-85744B49-4911-4331-BAEB-FECDE6A5AA06

Q37341453-87940EA0-11DF-412E-84B1-774CCE27B099

Q37341453-886A580E-AC88-4C61-AB59-2D5E2B380B79

Q37341453-8B70435D-900F-4E5C-8EA0-E607966A0B13

P2860

Q37341453-11630444-9E3D-4FAA-872E-163E6D350056

Q37341453-13CF446C-BE29-44B3-AA30-69AE27101028

Q37341453-19FE3A9A-C1BF-445B-A12D-95FFE08D5D0C

Q37341453-2EED054D-9E90-451A-BE22-6511B8BB11BB

Q37341453-3D299F6B-FCB9-4791-A756-A685AF176FFC

Q37341453-3E00B6AD-FA31-460F-AFF7-DC7ABB3BE4F6

Q37341453-4334BEC2-50E3-4425-B68F-C640AF886F23

Q37341453-4CF00777-7C77-4687-B10F-852D07551CC0

Q37341453-58755C21-7419-4676-9FBD-2A5E7949733E

Q37341453-5C7BE064-3BA1-4490-8C35-27F525859461

P2888

Q37341453-F8FE2CC9-9B1B-437D-9951-4DC64A572428

P304

Q37341453-796BE269-F0DB-43AC-8747-36F74E38ACEF

P31

Q37341453-FDDA4B83-F5DB-4171-85F1-F4EBDDD4064A

P356

Q37341453-3E362CD5-2F7E-4F91-BC1F-83940393339E

P407

Q37341453-6358996A-B536-44B1-9D8A-925C92AAC293

P433

Q37341453-3119E9C0-81A3-43EC-AF88-EC8DED7A0376

P478

Q37341453-55A45CAF-1DE3-4628-BD5E-DB79FD49E76E

P50

Q37341453-1B1B0BF9-0DFB-4912-9B1E-95B6D3928343

Q37341453-3E65809F-756E-4664-B1E9-9DB64BD87DA8

Q37341453-3ECFEDAD-10CB-4D10-ADD2-807771E4A904

Q37341453-8B09D911-EA34-4ABA-9B6E-250E2945C0B7

Q37341453-90B0D9AE-E2CA-4754-BE4C-2893DBD39876

Q37341453-92F71292-1551-46E1-BF70-779B098D4247

Q37341453-9389867C-3C70-49B1-B25F-C79F86BEA63E

Q37341453-962FD3B9-648F-4C06-8657-6A700588E89E

Q37341453-A6CEF23E-9A6E-461C-883D-26D35A9EB9F8

Q37341453-B5AB3161-FF58-4CB6-A8E6-559C1D3220E0

P577

Q37341453-854BEAC3-59B2-4F16-8284-846284195232

P5875

Q37341453-03A8DFBF-EF8C-4206-ABF3-2422364F4BF9

P698

Q37341453-BB62DDAC-A1F2-4826-832A-ACB01B97F881

P932

Q37341453-18C336C9-9533-449D-AE90-4803E31FD4E0

P356

P1433

Nature Genetics

P1476

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

@en

P2093

Alfredo Carrato

http://www.w3.org/2001/XMLSchema#string

Ana Sagrera

http://www.w3.org/2001/XMLSchema#string

Cristina Balbás-Martínez

http://www.w3.org/2001/XMLSchema#string

Eleonora Lapi

http://www.w3.org/2001/XMLSchema#string

Ivo Gut

http://www.w3.org/2001/XMLSchema#string

Josep Lloreta

http://www.w3.org/2001/XMLSchema#string

José A Lorente

http://www.w3.org/2001/XMLSchema#string

Juan C Cigudosa

http://www.w3.org/2001/XMLSchema#string

Julie Earl

http://www.w3.org/2001/XMLSchema#string

Laia Richart

http://www.w3.org/2001/XMLSchema#string

P2860

Chapter 14: Cancer genome analysis

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

The GEM mapper: fast, accurate and versatile alignment by filtration

A unique role of cohesin-SA1 in gene regulation and development

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

The origin and evolution of mutations in acute myeloid leukemia

Cohesin: its roles and mechanisms

P2888

P304

1464-1469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.2799

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Alfonso Valencia

Francesc Castro-giner

David G. Pisano

Francisco X Real

Adonina Tardón

P577

2013-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257754496

http://www.w3.org/2001/XMLSchema#string

P698

24121791

http://www.w3.org/2001/XMLSchema#string

P932

3840052

http://www.w3.org/2001/XMLSchema#string